Celltrion biosimilar among CHMP recommendations

EMA’s CHMP recommended approval of a basket of candidates on Friday, including biologics from Pfizer Inc. (NYSE:PFE) and Celltrion Inc. (KOSDAQ:068270).

CHMP recommended Pfizer’s Lifmior etanercept, a product identical

Read the full 286 word article

User Sign In